Cases & Deals

Canaccord Genuity underwrites follow-on public offering of Common Stock by GenMark Diagnostics

Clients Canaccord Genuity Inc.

Jones Day advised Canaccord Genuity Inc., as representative of the underwriters, in connection with the $34.5 million follow-on public offering of Common Stock on the NASDAQ Global Market by GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology.